LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Brandt, SD; Elliott, S
Publisher: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Languages: English
Types: Other
Subjects: RS
This publication presents the data and findings of the risk assessment on α-PVP (1-phenyl- 2-(1-pyrrolidinyl)-1-pentanone), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2015. α-PVP is the eleventh new psychoactive substance to be risk assessed under the terms of Council Decision 2005/387/JHA. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 June 2016, the Council decided that α-PVP should be subject to control measures across the Member States.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • | Aarde, S. M., Creehan, K. M., Vandewater, S. A., Dickerson, T. J. and Tafe, M. A. (2015), 'In vivo potency and eficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats', Psychopharmacology, 232(16), pp. 3045-3055.
    • | Amaratunga, P., Lemberg, B. L. and Lemberg, D. (2013), 'Quantitative measurement of synthetic cathinones in oral fluid', Journal of Analytical Toxicology, 37(9), pp. 622-628.
    • | Armenta, S., Garrigues, S., Guardia, M., Brassier, J., Alcala, M., Blanco, M., Perez-Alfonso, C. and Galipienso, N. (2015), 'Detection and characterization of emerging psychoactive substances by ion mobility spectrometry', Drug Testing and Analysis, 7(4), pp. 280-289.
    • | Bluelight (2015), www.bluelight.org/vb/threads/609259-Some-early-A-PVP-%28alpha-PVP%29-vsMDPV-comparisons (October).
    • | Borova, V. L., Gago-Ferrero, P., Pistos, C. and Thomaidis, N. S. (2015), 'Multi-residue determination of 10 selected new psychoactive substances in wastewater samples by liquid chromatography-tandem mass spectrometry', Talanta, 144, pp. 592-603.
    • | Casale, J. F. and Hays, P. A. (2012), 'The characterization of α-pyrrolidinopentiophenone', Microgram Journal, 9(1), pp. 33-38.
    • | Flashback (2015), https://www.flashback.org/u605277 (accessed October 2015).
    • | Fornal, E. (2014), 'Study of collision-induced dissociation of electrospray-generated protonated cathinones', Drug Testing and Analysis, 6(7-8), pp. 705-715.
    • | Friscia, M., Wolf, S. E., Mohr, A. L. A., Diamond, F. X., Yeakel, J. K. and Logan, B. K. (2015), 'Identification of major metabolites in human blood and urine associated with the ingestion of alpha-pyrrolidinopentiophenone (alpha PVP)', K55, 67th Proceedings of the American Academy of Forensic Sciences, 1125-1126 (www.aafs.org/sites/default/files/2015/2015Proceedings.pdf ).
    • | Fujii, H., Waters, B., Hara, K., Kashiwagi, M., Matsusue, A., Takayama, M. and Kubo, S.-i. (2015), 'Direct-heating headspace solid-phase microextraction for the screening of illicit drugs', Forensic Toxicology, 33(1), pp. 61-68.
    • | Gatch, M. B., Dolan, S. B. and Forster, M. J. (2015), 'Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives', Journal of Pharmacology and Experimental hTerapeutics , 354(2), pp. 103-110.
    • | Giese, C., Igoe, D., Gibbons, Z., Hurley, C., Stokes, S., McNamara, S., Ennis, O., O'Donnell, K., Keenan, E., De Gascun, C., Lyons, F., Ward, M., Danis, K., Glynn, R., Waters, A., and Fitzgerald, M. (2015), 'Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland', EuroSurveillance, 20(40): pii=30036.
    • | Guha, S., Rajeshkumar, V., Kotha, S. S. and Sekar, G. (2015), 'A versatile and one-pot strategy to synthesize α-amino ketones from benzylic secondary alcohols using N-bromosuccinimide', Organic Letters, 17(3), pp. 406-409.
    • | Hasegawa, K., Suzuki, O., Wurita, A., Minakata, K., Yamagishi, I., Nozawa, H., Gonmori, K. and Watanabe, K. (2014), 'Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC-MS-MS with the standard addition method', Forensic Toxicology, 32(2), pp. 225-234.
    • | Hayase, T., Yamamoto, Y. and Yamamoto, K. (1996), 'Protective efects of buprenorphine against amplified cocaine and ethanol lethality in mice: role of cocaethylene', Journal of Toxicological Sciences, 21(2), pp. 143-156.
    • | Hefe, W. (1966a), 'Verfahren zur Herstellung von α-pyrrolidino-valerophenonen', Patent No. CH 395998, Dr A. Wander A.G., Bern, Switzerland.
    • | Hefe, W. (1966b), 'Verfahren zur Herstellung von α-pyrrolidino-valerophenonen', Patent No. CH 395999. Dr A. Wander A.G., Bern, Switzerland.
    • | Hefe, W. (1966c). Verfahren zur Herstellung von α-pyrrolidino-valerophenonen. Patent No. CH 401054, Dr A. Wander A.G., Bern, Switzerland.
    • | Kaizaki, A., Tanaka, S. and Numazawa, S. (2014), ‚New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1- pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron', Journal of Toxicological Sciences, 39(1), pp. 1-6.
    • | Knoy, J. L., Peterson, B. L. and Couper, F. J. (2014), 'Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone', Journal of Analytical Toxicology, 38(8), pp. 615-617.
    • | Kolanos, R., Solis, E., Sakloth, F., De Felice, L. J. and Glennon, R. A. (2013), '”Deconstruction” of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of efects at the human dopamine transporter', ACS Chemical Neuroscience, 4(12), pp. 1524-1529.
    • | Kolanos, R., Sakloth, F., Jain, A. D., Partilla, J. S., Baumann, M. H. and Glennon, R. A. (2015), 'Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters›, ACS Chemical Neuroscience, doi: 10.1021/acschemneuro.1025b00160.
    • | Lefler, A. M., Smith, P. B., de Armas, A. and Dorman, F. L. (2014), 'The analytical investigation of synthetic street drugs containing cathinone analogs', Forensic Science International, 234, pp. 50-56.
    • | Marinetti, L. J. and Antonides, H. M. (2013), 'Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results', Journal of Analytical Toxicology, 37(3), pp. 135-146.
    • | Marusich, J. A., Antonazzo, K. R., Wiley, J. L., Blough, B. E., Partilla, J. S. and Baumann, M. H. (2014), 'Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)', Neuropharmacology, 87, pp. 206-213.
    • | McNamara, S., Stokes, S., Shine, A., Kildu,f R. and O'Byrne, P. (2015), 'New psychoactive substances prevalence in samples tested in the NDTC laboratory 2010-2015', European Network of Forensic Science Institutes Drugs Working Group, 5-8 May 2015, Dublin.
    • | Meltzer, P. C., Butler, D., Deschamps, J. R. and Madras, B. K. (2006), '1-(4-Methylphenyl)-2-pyrrolidin1-ylpentan-1-one (pyrovalerone) analogs: a promising class of monoamine uptake inhibitors', Journal of Medicinal Chemistry, 49(4), pp. 1420-1432.
    • | Meyer, M. R. and Maurer, H. H. (2010), 'Metabolism of designer drugs of abuse: an updated review', Current Drug Metabolism, 11(5), pp. 468-482.
    • | Minakata, K., Yamagishi, I., Nozawa, H., Hasegawa, K., Wurita, A., Gonmori, K., Suzuki, M., Watanabe, K. and Suzuki, O. (2014), 'MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood', Forensic Toxicology, 32(1), pp. 169-175.
    • | Nagai, H., Saka, K., Nakajima, M., Maeda, H., Kuroda, R., Igarashi, A., Tsujimura-Ito, T., Nara, A., Komori, M. and Yoshida, K.-i. (2014), 'Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinovalerophenone', International Journal of Cardiology, 172(1), pp. 263-265.
    • | Namera, A., Konuma, K., Saito, T., Ota, S., Oikawa, H., Miyazaki, S., Urabe, S., Shiraishi, H. and Nagao, M. (2013a), 'Simple segmental hair analysis for α-pyrrolidinophenone-type designer drugs by MonoSpin extraction for evaluation of abuse history', Journal of Chromatography B, 942-943, pp. 15-20.
    • | Namera, A., Urabe, S., Saito, T., et al. (2013b), 'A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of alpha-pyrrolidinobutiophenone and alpha-pyrrolidinovalerophenone in blood and/or hair', Forensic Toxicology, 31(2), pp. 338-343.
    • | Namera, A., Konuma, K., Kawamura, M., et al. (2014), 'Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human', Forensic Toxicology, 32(1), pp. 68-74.
    • | Naylor, J. E., Freeman, K. B., Blough, B. E., Woolverton, W. L. and Huskinson, S. L. (2015), 'Discriminative-stimulus efects of second generation synthetic cathinones in methamphetaminetrained rats', Drug and Alcohol Dependence, 149, pp. 280-284.
    • | Negreira, N., Erratico, C., Kosjek, T., van Nuijs, A. L. N., Heath, E., Neels, H. and Covaci, A. (2015), 'In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol', Analytical and Bioanalytical Chemistry, 407(19), pp. 5803-5816.
    • | Power, J. D., McDermott, S. D., Talbot, B., O'Brien, J. E. and Kavanagh, P. (2012), 'The analysis of amphetamine-like cathinone derivatives using positive electrospray ionization with in-source collision-induced dissociation', Rapid Communications in Mass Spectrometry, 26(22), pp. 2601- 2611.
    • | Richards-Waugh, L. L., Bailey, K. M., Clay, D. J., Gebhardt, M. A., Newsome-Sparks, C. L., E., M. H., Venuti, S. E. and Kraner, J. C. (2013), 'Deaths involving the recreational use of α-PVP (α-pyrrolidinopentiophenone)', K16, 65th Proceedings of the American Academy of Forensic Sciences, 521-522 (www.aafs.org/sites/default/files/pdf/ProceedingsWashingtonDC2013.pdf ).
    • | Rickli, A., Hoener, M. C. and Liechti, M. E. (2015), 'Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones', European Neuropsychopharmacology, 25(3), pp. 365-376.
    • | Saito, T., Namera, A., Osawa, M., Aoki, H. and Inokuchi, S. (2013), 'SPME-GC-MS analysis of alphapyrrolidinovaleorophenone in blood in a fatal poisoning case', Forensic Toxicology, 31(2), pp. 328-332.
    • | Sauer, C., Peters, F. T., Haas, C., Meyer, M. R., Fritschi, G. and Maurer, H. H. (2009), 'New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques', Journal of Mass Spectrometry, 44(6), pp. 952-964.
    • | Schneir, A., Ly, B. T., Casagrande, K., Darracq, M., Oferman, S. R., Thornton, S., Smollin, C., Vohra, R., Rangun, C., Tomaszewski, C. and Gerona, R. R. (2014), 'Comprehensive analysis of “bath salts” purchased from California stores and the Internet', Clinical Toxicology, 52(7), pp. 651-658.
    • | Seeger, E. (1964), 'Verfahren zur Herstellung von α-Pyrrolidinoketonen und deren Salzen', Patent No. DE 1161274, Dr Karl Thomae GmbH, Biberach an der Riss, Germany.
    • | Tsujikawa, K., Kuwayama, K., Kanamori, T., Iwata, Y. T. and Inoue, H. (2013), 'Thermal degradation of α-pyrrolidinopentiophenone during injection in gas chromatography/mass spectrometry', Forensic Science International, 231(1-3), pp. 296-299.
    • | Tyrkkö, E., Pelander, A., Ketola, R. A. and Ojanperä, I. (2013), 'In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-timeof-flight mass spectrometry', Analytical and Bioanalytical Chemistry, 405(21), pp. 6697-6709.
    • | Uchiyama, N., Matsuda, S., Kawamura, M., Shimokawa, Y., Kikura-Hanajiri, R., Aritake, K., Urade, Y. and Goda, Y. (2014), 'Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products', Forensic Science International, 243 pp. 1-13.
    • | Uralets, V., Rana, S., Morgan, S. and Ross, W. (2014), 'Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine', Journal of Analytical Toxicology, 38(5), pp. 233-241.
    • | Usdin, E. and Efron, D. H. (eds) (1972), 'Psychotropic drugs and related compounds (2nd ed.)', National Institute of Mental Health, Washington, District of Columbia, pp. 294.
    • | Watterson, L. R., Burrows, B. T., Hernandez, R. D., Moore, K. N., Grabenauer, M., Marusich, J. A. and Olive, M. F. (2014), 'Efects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation “bath salts,” on intracranial selfstimulation thresholds in rats', International Journal of Neuropsychopharmacology, 18(1), pp. doi: 10.1093/ijnp/pyu1014.
    • | Westphal, F., Junge, T., Klein, B., Fritschi, G. and Girreser, U. (2011), 'Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: a new designer drug with α-pyrrolidinophenone structure', Forensic Science International, 209(1-3), pp. 126-132.
    • | Wurita, A., Hasegawa, K., Minakata, K., Gonmori, K., Nozawa, H., Yamagishi, I., Suzuki, O. and Watanabe, K. (2014), 'Postmortem distribution of alpha-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver', Legal Medicine, 16(5), pp. 241-246.
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Download from

Cite this article